Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma

NCT01854606

Conditions
CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Washington University School of Medicine Dept of Oncology. St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center Onc. Dept. New York, United States
  • Sarah Cannon Research Institute Dept of Onc Nashville, Tennessee, United States
  • Novartis Investigative Site Rouen, France
View all 15 locations
View Trial Details
Completed

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

NCT00670592

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • St. Francis Cancer Research Foundation Dept.ofSt.FrancisCancerRes.(2) Beech Grove, Indiana, United States
  • Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States
  • Wake Forest University Baptist Medical Center Dept. of Industry Research (2) Winston-Salem, North Carolina, United States
View all 28 locations
View Trial Details
Completed

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.

NCT01237236

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering MSKCC (2) New York, United States
  • Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) Nashville, Tennessee, United States
View Trial Details
Completed

Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma

NCT01956695

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Centre Léon Bérard Lyon, Auvergne-Rhône-Alpes, France
  • CHU Estaing Clermont-Ferrand, Auvergne, France
  • CHU Bretonneau - Centre Henry Kaplan Tours, Centre-Val de Loire, France
  • Institut Bergonié Bordeaux, Gironde, France
View Trial Details
Completed

Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma

NCT01275209

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States
  • Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States
  • Duke University Medical Center Duke Hem & Onc Durham, North Carolina, United States
  • Sarah Cannon Research Institute SC - 2 Chattanooga, Tennessee, United States
View Trial Details

Related conditions